Clinical Trial: Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain Injury

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935278) titled 'Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain Injury' on Nov. 09.

Brief Summary: This Phase II clinical trial protocol will provide evidence as to whether IN insulin is efficacious in reducing symptoms in people seeking care for mild TBI (concussion).

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Concussion (Diagnosis) Mild Traumatic Brain Injury

Intervention: DRUG: Insulin (Humulin)

Intranasal regular insulin

DRUG: Placebo

Intranasal saline

Recruitment Status: RECRUITING

Sponsor: HealthPartners Institute

Published by HT Digital Content Services wit...